《藍籌業績》農夫山泉(09633.HK)全年純利84.95億人民幣增18.6% 末期息派68分
農夫山泉(09633.HK)公布2022年止年度業績,總收益332.39億俁幣(下同),按年增加11.9%。錄得純利84.95億元,增長18.6%,每股盈利76分。末期息68分,上年同期派45分。
年內,毛利190.95億元,增加8.2%;毛利率下降2.1個百分點至57.4%,主要因國際原油價格變動導致PET採購成本提高。
2022年,包裝飲用水產品錄得收益182.63億元,增長7.1%,佔總收益54.9%;茶飲料產品持續受到消費者認可和歡迎,全年收益69.06億元,增長50.8%,佔總收益20.8%,提升5.4個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.